Financials Ardelyx, Inc.

Equities

ARDX

US0396971071

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
6.42 USD +1.74% Intraday chart for Ardelyx, Inc. -0.93% +3.55%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 644 583.9 124 534.3 1,439 1,494 - -
Enterprise Value (EV) 1 445.3 583.9 124 534.3 1,439 1,494 1,494 1,494
P/E ratio -5.11 x -6.16 x -0.72 x -6.79 x -20.7 x -14.3 x 233 x 9.81 x
Yield - - - - - - - -
Capitalization / Revenue 122 x 77.1 x 12.3 x 10.2 x 11.6 x 7.15 x 4.07 x 2.65 x
EV / Revenue 122 x 77.1 x 12.3 x 10.2 x 11.6 x 7.15 x 4.07 x 2.65 x
EV / EBITDA -7.26 x -6.56 x -0.88 x -10.3 x -29.7 x -26.8 x 15.9 x 6.26 x
EV / FCF -8.38 x -7.14 x -0.8 x -7.62 x - -20.5 x -1,057 x 8.69 x
FCF Yield -11.9% -14% -125% -13.1% - -4.88% -0.09% 11.5%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 85,807 90,248 112,743 187,460 232,138 232,686 - -
Reference price 2 7.505 6.470 1.100 2.850 6.200 6.420 6.420 6.420
Announcement Date 3/6/20 3/8/21 2/28/22 3/2/23 2/22/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 5.281 7.571 10.1 52.16 124.5 208.8 367 563.1
EBITDA 1 -88.76 -88.96 -140.2 -51.86 -48.45 -55.76 94.07 238.5
EBIT 1 -91.26 -90.78 -154.3 -63.76 -63.28 -103.7 19.3 173.4
Operating Margin -1,728.14% -1,199.05% -1,528.63% -122.24% -50.84% -49.69% 5.26% 30.79%
Earnings before Tax (EBT) 1 -94.94 -94.31 -158.2 -67.2 -65.52 -108 4.189 169.6
Net income 1 -94.94 -94.31 -158.2 -67.21 -66.07 -106.8 6.787 167.7
Net margin -1,797.77% -1,245.71% -1,566.46% -128.85% -53.08% -51.13% 1.85% 29.79%
EPS 2 -1.470 -1.050 -1.520 -0.4200 -0.3000 -0.4489 0.0275 0.6543
Free Cash Flow 1 -76.81 -81.76 -154.4 -70.1 - -72.84 -1.413 172
FCF margin -1,454.44% -1,079.9% -1,529.35% -134.4% - -34.89% -0.38% 30.54%
FCF Conversion (EBITDA) - - - - - - - 72.1%
FCF Conversion (Net income) - - - - - - - 102.53%
Dividend per Share 2 - - - - - - - -
Announcement Date 3/6/20 3/8/21 2/28/22 3/2/23 2/22/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 1.173 1.029 0.468 2.526 4.986 44.18 11.37 22.33 56.39 34.36 35.81 46.97 56.88 67.61 75.83
EBITDA 1 -39.51 -31.45 -23.68 -22.73 -19.63 14.18 -23.15 -13.42 11.18 -23.69 -23.25 -15.08 -13.11 -4.317 2.666
EBIT 1 -42.24 -35.27 -27.81 -26.22 -21.88 12.14 -26.06 -16.62 7.398 -27.99 -33.57 -28.7 -24.59 -16.93 -11.37
Operating Margin -3,600.68% -3,427.89% -5,941.67% -1,037.81% -438.83% 27.49% -229.25% -74.44% 13.12% -81.44% -93.73% -61.1% -43.23% -25.04% -14.99%
Earnings before Tax (EBT) 1 -43.59 -36.23 -28.07 -26.93 -22.89 10.7 -26.76 -17.12 6.829 -28.47 -34.5 -29.77 -25.68 -18.02 -12.27
Net income 1 -43.59 -36.23 -28.07 -26.94 -22.89 10.7 -26.77 -17.12 6.629 -28.8 -34.26 -29.6 -25.1 -17.79 -12.56
Net margin -3,715.86% -3,521.28% -5,998.08% -1,066.43% -459.15% 24.21% -235.49% -76.66% 11.76% -83.82% -95.66% -63.01% -44.13% -26.32% -16.56%
EPS 2 -0.4200 -0.3100 -0.2100 -0.1900 -0.1400 0.0600 -0.1300 -0.0800 0.0300 -0.1200 -0.1478 -0.1256 -0.1056 -0.0711 -0.0533
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 11/12/21 2/28/22 5/5/22 8/4/22 11/3/22 3/2/23 5/3/23 8/2/23 10/31/23 2/22/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position 199 - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 -76.8 -81.8 -154 -70.1 - -72.8 -1.41 172
ROE (net income / shareholders' equity) - - -152% -74.3% -49.8% -24.6% 42.9% -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 0.33 0.32 1.87 0.06 0.34 1.09 1.1 1.11
Capex / Sales 6.15% 4.28% 18.49% 0.11% 0.28% 0.52% 0.3% 0.2%
Announcement Date 3/6/20 3/8/21 2/28/22 3/2/23 2/22/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
6.42 USD
Average target price
13.5 USD
Spread / Average Target
+110.28%
Consensus
  1. Stock Market
  2. Equities
  3. ARDX Stock
  4. Financials Ardelyx, Inc.